Related Experiment Videos
West's syndrome
1Division of Pediatric Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1752, USA. wshieldsm@mednet.ucla.edu
Insights
West's syndrome, a severe childhood epilepsy, remains poorly understood despite its long history. This review covers its causes, current treatments, and potential therapeutic strategies for infantile spasms.
Area of Science:
- Pediatric Neurology
- Epileptology
- Clinical Therapeutics
Background:
- West's syndrome, also known as infantile spasms, is a critical epilepsy disorder in childhood.
- Despite being identified 160 years ago, the exact causes and mechanisms of West's syndrome are not fully elucidated.
- The complexity of its multiple etiologies complicates diagnosis and treatment, with no specific FDA-approved drugs currently available.
Purpose of the Study:
- To review the diverse etiologies associated with West's syndrome.
- To discuss the antiepilepsy drug therapies currently employed for infantile spasms.
- To explore other available treatment options for clinicians managing this condition.
Main Methods:
- Literature review of established and emerging research on West's syndrome.
- Analysis of current clinical practices and therapeutic guidelines.
- Synthesis of information on various treatment modalities for infantile spasms.
Main Results:
- West's syndrome presents with varied underlying causes, necessitating a comprehensive diagnostic approach.
- Current treatment strategies involve a range of antiepilepsy drugs, often used off-label.
- A logical, sequential approach to treatment is recommended, considering all available therapeutic options.
Conclusions:
- Understanding the multiple etiologies of West's syndrome is crucial for effective management.
- A broad therapeutic perspective, exploring all available options, is essential for treating infantile spasms.
- Further research is needed to develop targeted therapies and improve outcomes for children with West's syndrome.
Abstract:
West's syndrome (infantile spasms) can be considered the classic disorder of the catastrophic childhood epilepsies. Although West's syndrome was identified 160 years ago, it is still not fully understood today. Because of the multiple etiologies associated with West's syndrome, the evaluation and treatment of the disease are complex, and, to date, there are no drugs approved by the US Food and Drug Administration specifically for the treatment of infantile spasms. The multiple etiologies associated with infantile spasms require that physicians take a broad look at all therapeutic options. There are, however, logical sequences that physicians should pursue when trying to treat this disorder. This article reviews the etiologies associated with West's syndrome, antiepilepsy drug therapies currently being used to treat the syndrome, and other treatment options available to clinicians.